| Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) | Phase 2 | Sparrow Pharmaceuticals | 2 mi |
| A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma | Phase 2 | Children's Oncology Group | 2 mi |
| PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes | Phase 4 | Brigham and Women's Hospital | 2 mi |
| My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes | N/A | University of Illinois at Chicago | 2 mi |
| Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease | Phase 3 | Alessandro Doria | 2 mi |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | Phase 3 | Boehringer Ingelheim | 2 mi |
| Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers | N/A | Piomic Medical | 2 mi |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) | Phase 1/2 | COUR Pharmaceutical Development Company, Inc. | 2 mi |
| Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease | Phase 2 | Regeneron Pharmaceuticals | 2 mi |
| Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant | — | University of Chicago | 2 mi |
| Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes | Phase 3 | Kailera | 2 mi |
| Circadian Mechanisms, Glucose, and CV Risks in T1D | N/A | University of Illinois at Chicago | 2 mi |
| A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes | Phase 2 | Zucara Therapeutics Inc. | 2 mi |
| A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events | N/A | Cleerly, Inc. | 2 mi |
| Role of Adiposomes in Endothelial Dysfunction | N/A | University of Illinois at Chicago | 2 mi |
| Diabetes RElated to Acute Pancreatitis and Its Mechanisms | — | Milton S. Hershey Medical Center | 2 mi |
| Islet Transplantation in Patients With "Brittle" Type I Diabetes | N/A | University of Chicago | 2 mi |
| Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics | — | Milton S. Hershey Medical Center | 2 mi |
| Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes | Phase 4 | VA Office of Research and Development | 2 mi |
| Diabetic Neuropathy in Spinal Cord Stimulator Patients | — | University of Chicago | 2 mi |
| Type 1 Diabetes and Obstructive Sleep Apnea | N/A | University of Chicago | 2 mi |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort | Phase 1 | AstraZeneca | 2 mi |
| Islet Transplantation in Type 1 Diabetic Kidney Allograft | Phase 2 | University of Chicago | 2 mi |
| Registry for Stage 2 Type 1 Diabetes | — | Sanofi | 2 mi |
| Vasoactive Drugs in Intensive Care Unit | Phase 4 | University of Chicago | 2 mi |
| Sleep, Diabetic Retinopathy and Melatonin | Phase 2 | University of Illinois at Chicago | 2 mi |
| MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors | N/A | Clinical Nutrition Research Center, Illinois Institute of Technology | 2 mi |
| A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes | Phase 3 | Vertex Pharmaceuticals Incorporated | 2 mi |
| A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin | Phase 3 | Eli Lilly and Company | 2 mi |
| Enhancing Diabetes Care: Exposome &Amp; Sensors | — | University of Illinois at Chicago | 2 mi |
| A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus | Phase 1/2 | Otsuka Pharmaceutical Factory, Inc. | 2 mi |
| Rare and Atypical Diabetes Network | — | University of South Florida | 2 mi |
| A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) | Phase 3 | Eli Lilly and Company | 2 mi |
| CBTi for the Treatment of Insomnia in Type 1 Diabetes | Early 1 | University of Illinois at Chicago | 2 mi |
| Transformative Research in Diabetic Nephropathy | — | University of Pennsylvania | 2 mi |
| A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers | N/A | Jill Weissberg-Benchell, Ph.D. | 2 mi |
| Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial | N/A | Sonavex, Inc. | 2 mi |
| Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE) | N/A | University of Illinois at Chicago | 2 mi |
| ECHO Diabetes FQHC | — | University of Florida | 2 mi |
| Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs | N/A | California Polytechnic State University-San Luis Obispo | 2 mi |
| Achieving Routine Intervention and Screening for Emotional Health | N/A | University of Chicago | 2 mi |
| A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus | Phase 2 | Corxel Pharmaceuticals | 2 mi |
| Kidney Precision Medicine Project | — | Icahn School of Medicine at Mount Sinai | 2 mi |
| Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus | Phase 2 | Op-T LLC | 2 mi |
| A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight | Phase 3 | Novo Nordisk A/S | 2 mi |
| A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes | Phase 2 | Novo Nordisk A/S | 2 mi |
| Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema | Phase 2/3 | AbbVie | 2 mi |
| Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System | N/A | Insulet Corporation | 2 mi |
| A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight | Phase 2 | Eli Lilly and Company | 2 mi |
| A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus | Phase 3 | AstraZeneca | 2 mi |
| Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study | — | Indiana University | 2 mi |
| Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes | N/A | Insulet Corporation | 2 mi |
| Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes | — | Clinical Nutrition Research Center, Illinois Institute of Technology | 2 mi |
| A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity | Phase 3 | Pfizer | 2 mi |
| Food and Metabolism Study | N/A | Clinical Nutrition Research Center, Illinois Institute of Technology | 2 mi |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin | Phase 3 | AstraZeneca | 2 mi |
| Preventative Screening and Health Coaching in a Food Insecure Population | N/A | Rush University Medical Center | 2 mi |
| A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus | Phase 3 | AstraZeneca | 2 mi |
| A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus | Phase 3 | AstraZeneca | 2 mi |
| Empagliflozin Treatment in Kidney Transplant Recipients | Phase 4 | VA Office of Research and Development | 11 mi |
| RCT Glargine vs NPH for Treatment of DM in Pregnancy | Phase 3 | Loyola University | 11 mi |
| Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers | N/A | Omeza, LLC | 12 mi |
| A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies | — | AstraZeneca | 12 mi |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM | Phase 3 | AstraZeneca | 12 mi |
| A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus | Phase 3 | AstraZeneca | 12 mi |
| A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease | Phase 2 | Novo Nordisk A/S | 12 mi |
| Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes | Phase 3 | Kailera | 12 mi |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes | Phase 3 | Eli Lilly and Company | 12 mi |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes | Phase 3 | Hoffmann-La Roche | 12 mi |
| A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar | Phase 3 | Boehringer Ingelheim | 12 mi |
| AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications | Phase 3 | Novo Nordisk A/S | 16 mi |
| A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01 | Phase 2 | Vantage Biosciences Ltd | 16 mi |
| Study of WAL0921 in Patients With Glomerular Kidney Diseases | Phase 2 | Walden Biosciences | 17 mi |
| Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes | N/A | Nanjing Nutrabuilding Bio-tech Co., Ltd. | 19 mi |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy | Phase 1 | Hoffmann-La Roche | 20 mi |
| A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes | Phase 3 | Ascletis Pharma (China) Co., Limited | 26 mi |
| Effects of Walking in Greenspace and the Built Environment in Adults With Prediabetes: A Randomized Crossover Trial | N/A | University of Minnesota | 27 mi |
| Impact of Removable Cast Walker Design on Usability for Patients With Diabetic Foot Ulcers | N/A | Rosalind Franklin University of Medicine and Science | 33 mi |